Achillion Pharmaceuticals' CEO Hosts Sovaprevir Clinical Program Update

Achillion Pharmaceuticals' CEO Hosts Sovaprevir Clinical Program Update
Aside from these studies that I just mentioned, the drug-drug interaction study that I mentioned, we have completed 7 other drug-drug interaction studies, which includes DDI studies with methadone, Midazolam, oral contraceptives, digoxin, atorvastatin …
Read more on Seeking Alpha

Comments are closed.